FDA-EMA Advice Pilot For Complex Generics: What Does Industry Have To Say?
Voices From Medicines For Europe, Association For Accessible Medicines And Sandoz
The FDA and EMA have shared perspectives on the parallel scientific advice pilot for complex generics. Now industry stakeholders discuss whether transatlantic convergence is possible or merely a good idea on paper.
